Sean Carroll Mindscape
Episode overview

353 | Alvin Roth on the Economics of Morally Contested Markets

Sean Carroll Mindscape · 11 May 2026 · 5 Egleze moments
353 | Alvin Roth on the Economics of Morally Contested Markets ▶

What happened in this episode?

In this episode of Mindscape, host Sean Carroll interviews Nobel Prize-winning economist Alvin Roth of Stanford University about his new book, Moral Economics: From Prostitution to Organ Sales, What Controversial Transactions Reveal About How Markets Work. Roth, a pioneering market designer, challenges listeners to reconsider which transactions society should permit or prohibit, arguing that moral judgments about markets must account for real-world consequences, not just intentions. The conversation opens with Roth distinguishing between commodity markets where prices do all the work and matching markets like employment or kidney exchange where relationships matter. He introduces the concept of "repugnant transactions"—exchanges some people want to engage in but others morally oppose—using examples ranging from same-sex marriage and abortion to kidney sales and drug markets. A central revelation is that Iran is the only country allowing paid kidney donation, while the U.S. has 90,000 people on transplant waiting lists and most die without receiving organs. Roth designed kidney exchange systems that facilitate transplants without payment and advocates for the End Kidney Deaths Act, which would compensate anonymous donors through tax credits. He exposes how the U.S. exports tens of billions in paid blood plasma while other nations ban payment yet depend on American supply, and notes research showing plasma donation centers reduce payday loan dependency. Perhaps most striking is Roth's comparison of drug prohibition versus the hitman market: identical harsh penalties successfully eliminated commercial assassination but utterly failed to curb drug addiction, with over 40% of federal prisoners incarcerated for drug offenses while overdoses continue. He calls for experimentation and evidence-based policy rather than purely moral positions, noting even prisons cannot keep drugs out. The episode concludes with Roth discussing medical aid in dying, revealing that Justices Gorsuch and Barrett previously opposed it and predicting Supreme Court intervention similar to abortion. Throughout, Roth emphasizes that markets are human artifacts requiring thoughtful design, and that both markets and market bans need social support to function—support that exists for preventing contract killing but has failed catastrophically for drug prohibition.

What are the key points?

Which topics are covered?

How is this page sourced?

Programme
Sean Carroll Mindscape
Published
11 May 2026
Original episode
Open the original source ↗

Egleze verifies the speaker, source and timestamp for each linked moment. Unless a moment is explicitly marked independently verified, statements remain attributed claims by the named speaker rather than established facts.

Watch original episode More from Sean Carroll Mindscape

5 moments from this episode

Source-linked · editorially selected
01
Crime & Justice

Stanford Economist Claims Drug War Fails While Hitman Market Successfully Suppressed

at 28:28 · Attributed speaker claim
Why is it easy to buy drugs but hard to hire a hitman? Our laws are the same. If we catch drug dealers or hitmen, we put them away for a long time, but it's working for hitmen. There's very little market for commercial killing. The same laws that work so well against hitmen aren't working so well against drugs.

Alvin Roth argued that identical legal penalties produce radically different outcomes: commercial assassination has been virtually eliminated while drug markets thrive despite enforcement. He noted that over 40% of federal prisoners have drug convictions yet overdose deaths remain high, and cited the inability to keep drugs out of prisons as evidence that purely police and military methods have failed.

02
Society

Economist Reveals Why Iran Alone Allows Legal Kidney Sales for Transplants

at 37:40 · Attributed speaker claim
It's against the law to pay someone to be a kidney donor almost everywhere with a single exception, which is the Islamic Republic of Iran. I've read the Shia fatwas, the religious rulings that allow it, and they just say, you know, it's not so bad. It saves a life.

Nobel Prize-winning economist Alvin Roth explained that Iran is the only country in the world where paying kidney donors is legal, sanctioned by Shia religious rulings that prioritize life-saving. Meanwhile, the U.S. has 90,000 people on kidney transplant waiting lists with fewer than 30,000 transplants performed annually, resulting in thousands of preventable deaths. Roth suggests the federal government could legally purchase kidneys as a national resource distributed by medical need, though he acknowledges this reform is unlikely.

03
Society

Nobel Laureate Reveals U.S. Exports Tens of Billions in Paid Plasma While Other Countries Ban Payment

at 41:10 · Attributed speaker claim
We export tens of billions of dollars of plasma and plasma products every year because we pay donors. There's no shortage of plasma here. And the people who donate plasma are on the whole not as rich as the people who don't donate plasma. It's something people do to supplement their income.

Roth disclosed that the United States is the world's plasma supplier, exporting tens of billions annually, while most other countries ban paying plasma donors yet rely on U.S. imports. He cited recent research showing that when plasma facilities open, payday loan usage drops, suggesting paid plasma donation provides crucial income supplementation for struggling Americans. The World Health Organization lists plasma as an essential pharmaceutical but recommends against paying donors.

04
Politics

Roth Says New Legislation Could Save Lives by Paying Kidney Donors Through Tax Credits

at 48:15 · Attributed speaker claim
Right now, there's periodically much less ambitious legislation in front of Congress. A bill that's trying to make its way through Congress is called the End Kidney Deaths Act. And it would give a limited compensation through income tax credits to non-directed donors, to kidney donors who donate a kidney anonymously without specifying who it should go to.

Roth discussed pending congressional legislation that would compensate anonymous kidney donors through tax credits rather than direct payment. He explained that the U.S. currently has only about 500 non-directed donors annually, and that doubling this number through modest compensation would be cost-effective given Medicare's expenses for kidney patients. The bill represents a compromise approach to expanding kidney supply while avoiding direct organ sales.

05
Politics

Supreme Court Justices Gorsuch and Barrett Previously Opposed Medical Aid in Dying

at 1:10:25 · Attributed speaker claim
Now we have two Supreme Court justices presently, Gorsuch and Amy Coney Barrett, who have written in the past before they were justices about their opposition to medical aid in dying. So I wouldn't be surprised if like abortion, it comes again before the Supreme Court.

Roth revealed that both Justice Neil Gorsuch and Justice Amy Coney Barrett have written opposing medical aid in dying before joining the Court, predicting the issue could reach the Supreme Court similar to abortion. He noted that 12 or 13 U.S. states now allow medical aid in dying under restrictive circumstances, and cited Nobel laureate Daniel Kahneman's decision to travel to Switzerland to end his life as an example of fertility tourism for end-of-life care.